Research · 9 min read
How a Prescription Drug Gets From a Factory to Your Door
Between the company that makes a medication and the person who takes it sit several separate businesses, each with its own license and its own legal name for what it does. Knowing the shape of that chain is what makes a vague answer about your order recognizable.
Key takeaways
- FDA describes the ordinary path as ingredient supplier, manufacturer, wholesale distributor, pharmacy, patient — with repackagers and secondary distributors on the longer version.
- A third-party logistics provider moves the product without ever owning it, which is what a fulfillment partner often is.
- Manufacturers and repackagers register federally; distributors, logistics providers and pharmacies hold licenses, with pharmacies licensed by the state.
- FDA states that a wholesale distributor's annual report to the agency does not mean the facility is licensed or approved by FDA.
- Pharmacies must accept only drugs that arrive with product tracing documentation and must keep it for six years.
- Lawfully compounded drugs are carved out of the tracing definition, so that documentation trail does not attach to them.
Answer first: it is a chain, not a handoff
A finished prescription drug does not travel from a factory to you. It passes through a series of businesses that buy it, hold it, and sell it on, and each one is licensed separately to do its part.
FDA describes the ordinary path plainly. A drug starts with the supplier of the active pharmaceutical ingredient and moves to the manufacturer. From there it typically moves to a wholesale drug distributor, then to a pharmacy or hospital, and finally to the patient.
The agency also describes a longer version of the same path. A product may go from the manufacturer to a repackager, then through a primary or secondary wholesale distributor, before it reaches the pharmacy and the patient.
So the honest count of parties is usually four or five, not two. A program that answers a supply question by naming only itself has skipped most of them.
The five roles, in the law's own words
Federal law defines each link, and the definitions are more specific than the everyday words suggest. They sit in the definitions section of the Drug Supply Chain Security Act.
A manufacturer is the person holding the approved application or license for the product, or, if there is no approved application, the person who actually made it. Co-licensed partners and certain affiliates count too, which is why one drug can have more than one entity behind it.
A repackager owns or operates an establishment that repacks and relabels a product for further sale or for distribution. A wholesale distributor is a person engaged in wholesale distribution who is not the manufacturer, a co-licensed partner, a logistics provider or a repackager.
A dispenser is a retail pharmacy, a hospital pharmacy, a group of chain pharmacies under common ownership, or any other person authorized by law to dispense or administer prescription drugs. That is the entity that actually fills your prescription.
The link that never owns your medication
There is a fifth role worth knowing, because it is the one people most often mistake for a pharmacy. A third-party logistics provider coordinates warehousing or other logistics services on behalf of a manufacturer, wholesale distributor or dispenser.
The statutory definition then says exactly what it is not. Such a provider does not take ownership of the product, and has no responsibility to direct its sale or disposition. It holds the box and moves it.
A related role handles the reverse direction. A returns processor, also called a reverse logistics provider, takes back saleable or unsaleable product so it can be credited or disposed of.
When a company describes a fulfillment partner, one of these is often what it means. That partner is a real regulated entity, and it is not the party that decided you should receive the medication.
Licensed, registered and reported are three different words
Each link answers to a different authority, and the vocabulary is not interchangeable. Manufacturers and repackagers hold a federal registration. Wholesale distributors and third-party logistics providers hold licenses, and pharmacies hold a license under state law.
FDA runs a reporting database for the middle of the chain. Wholesale distributors and third-party logistics providers must be appropriately licensed and must report licensure and other information to the agency every year to be authorized trading partners.
That database carries a caution worth repeating in full. FDA states that reporting by a wholesale distributor or third-party logistics provider does not mean the facility is licensed or approved by FDA, or that it complies with applicable state and federal regulations.
The same database also states what it leaves out. It does not contain establishments registered as drug establishments under section 510, and it does not contain outsourcing facilities registered under section 503B. Those live in separate registries.
What the pharmacy at the end is required to do
The pharmacy is not merely the last stop. FDA describes three duties that sit on dispensers, and they are the reason a legitimate chain leaves a paper trail.
First, confirm that the entities it does business with are licensed or registered. FDA points pharmacists at the registration records for manufacturers and repackagers, the licensing records for distributors and logistics providers, and the state authority for other pharmacies.
Second, accept prescription drugs only when they arrive with product tracing documentation, and keep that documentation for six years. If a trading partner does not supply all of it, FDA tells pharmacies to work with them until it arrives.
Third, have a process for suspect and illegitimate drugs. That covers products that may be counterfeit, diverted, stolen, intentionally adulterated or unfit for distribution, and it requires quarantining and investigating them rather than shelving them.
Where a compounded product joins a different path
A compounded medication does not travel the route above, and that is a matter of definition rather than opinion. The tracing law applies to a category it calls a product, and the definition of that category carves out drugs compounded in compliance with the two compounding sections of federal law.
So the documentation trail described here does not attach to a lawfully compounded preparation. It is not a gap someone forgot to close. It is written into the statute.
The compounding route has its own chain and its own conditions, running from the supplier of the bulk active ingredient to the pharmacy or outsourcing facility that prepares the finished preparation. Different rules govern each step of it.
Neither path is a verdict on the other. They are simply different systems, and a question that assumes the wrong one produces an answer that sounds evasive when it is only mismatched.
What shipping to your home does and does not change
Mail delivery adds a leg to the end of the chain. It does not remove any of the earlier ones, and it does not change who is licensed to do what.
It does change what you can observe. In a walk-in pharmacy the label, the carton and the person handing it over are all in front of you. In a mailed order, the box is your first and often only look at the chain that produced it.
It also concentrates a common failure. FDA notes that when a person cannot get a medication locally, the cause is usually a temporary local supply issue. It says these often involve distribution problems that resolve once the pharmacy can reorder from its distributor.
That is a useful thing to hold onto. An empty shelf is a statement about one counter on one day, and it is a different claim from a national supply problem.
The questions this makes askable
Ask which pharmacy will dispense your prescription, by name and state. That is the entity holding the license, the records and the tracing duties, and it is a fact the seller knows.
Ask whether the medication is an approved product or a compounded preparation, because the two travel different routes with different documentation behind them.
Ask who ships it, if that is a separate company. A logistics partner that never owns the medication is normal, and knowing it is one tells you which questions it cannot answer.
A program that can name these parties is describing a real chain. A program that answers every question with its own brand name is describing a storefront, and the storefront is the part of this system with the fewest obligations attached.
Sources
- Graphic | A Drug Supply Chain ExampleThe ordinary path from active pharmaceutical ingredient supplier to manufacturer to wholesale drug distributor to pharmacy or hospital to patient; and the longer variant in which a product moves from the manufacturer to a repackager and then through a primary or secondary wholesale distributor before reaching the pharmacy.
- 21 U.S.C. 360eee — Definitions (Federal Food, Drug, and Cosmetic Act section 581)The definitions of manufacturer, repackager, wholesale distributor, dispenser, third-party logistics provider and returns processor or reverse logistics provider; the statement that a third-party logistics provider does not take ownership of the product nor have responsibility to direct its sale or disposition; the meaning of authorized and licensed for each role, including a dispenser's valid license under state law; and the exclusion of a drug compounded in compliance with sections 353a and 353b from the definition of product.
- Annual Licensure Reporting by Wholesale Drug Distributors and Third-Party Logistics ProvidersThe annual licensure reporting requirement for wholesale drug distributors and third-party logistics providers as a condition of being authorized trading partners; the database being updated every business day; the statement that reporting does not mean the facility is licensed or approved by FDA or in compliance with applicable state and federal regulations; and the exclusion from that database of section 510 drug establishments and section 503B outsourcing facilities.
- Pharmacists: Utilize DSCSA Requirements to Protect Your PatientsThe three duties described for dispensers: confirming that trading partners are licensed or registered, accepting only prescription drugs accompanied by product tracing documentation and storing it for six years, and maintaining a process to quarantine and investigate suspect and illegitimate drugs; and the description of suspect and illegitimate drugs as products that may be counterfeit, diverted, stolen, intentionally adulterated or unfit for distribution.
- Frequently Asked Questions about Drug ShortagesThe statement that reports of a medication being hard to find are usually temporary and often involve distribution issues that resolve when the pharmacy is able to reorder from its distributor.
Frequently asked questions
Who actually makes the medication I get in the mail?
For an approved product, the manufacturer is the entity holding the approved application or license for that drug, or the entity that made it if there is no approved application. Federal law also treats co-licensed partners and certain affiliates as manufacturers, so more than one company can sit behind a single product. The telehealth company you ordered from is almost never any of them. It is a seller of a service, and the manufacturer, the distributor and the dispensing pharmacy are separate businesses with separate licenses.
Is a fulfillment partner the same thing as a pharmacy?
No, and federal law separates them by name. A third-party logistics provider coordinates warehousing or other logistics services on behalf of a manufacturer, wholesale distributor or dispenser. It does not take ownership of the product, and has no responsibility to direct its sale or disposition. A dispenser is a pharmacy or another person authorized by law to dispense prescription drugs, and holds a state license to do it. A company can use both, and the shipping partner is not the one that filled the prescription.
Does FDA license the wholesalers in the middle?
Not in the way the word suggests. Wholesale distributors and third-party logistics providers must be appropriately licensed and must report licensure and other information to FDA each year to be authorized trading partners. FDA publishes that reporting in a searchable database updated every business day. The agency states directly that reporting does not mean the facility is licensed or approved by FDA, or that it complies with applicable state and federal regulations. The reporting is a disclosure, not a seal.
Why does the pharmacy keep paperwork for six years?
Because product tracing documentation is what allows a drug to be traced back through the chain if something goes wrong. FDA instructs pharmacies to accept prescription drugs only when accompanied by that documentation and to store it for six years. The same records let a recall, or an investigation into a suspect product, follow the medication back toward the manufacturer. A pharmacy that sells a drug on to another trading partner has to pass the documentation along, though not when it dispenses to a patient.
Does this tracing system cover compounded medications?
No. The tracing law applies to what it defines as a product, and that definition excludes a drug compounded in compliance with the federal compounding sections. So the transaction documentation, the package-level identifiers and the six-year records described here do not attach to a lawfully compounded preparation. That is a written exclusion rather than an oversight. Compounded preparations are governed by a different set of conditions, including limits on where the bulk active ingredient may come from and what the pharmacy may prepare.